Phase 1/2 trial evaluating the proprietary combination to be run under CRADA with the National Cancer Institute Second Versamune® platform candidate targets MUC1-positive solid tumors U.S. Patent #12, ...

Researcher suggests compounds secreted by high-risk MSCs that are detectable in the bloodstream could act as biomarkers for ...

The NCI will lead the trial of the firm's Versamune MUC1 immunotherapy and its antibody-drug conjugate PDS01ADC.

While both are called medullary carcinoma, these cancers differ in many ways: ...

Colorectal cancer is a term that combines both colon and rectal cancers. The colon and rectum are two different parts of the ...

Jessica Wozniak thought that some of the symptoms of norovirus were lingering. They were signs of Stage 4 colon cancer.

A discovery by Mayo Clinic researchers may help explain why immunotherapy hasn't been helpful for many patients with ...

Cancer-associated fibroblasts (CAFs) play an important role in metastatic melanoma, and an enhanced understanding of that role could lead to important new therapeutic pathways, according to a new ...

Researchers sought to evaluate differences in ctDNA profiles, use of targeted treatments, and overall survival between Black and White patients with metastatic breast cancer.

mRCC, metastatic renal cell carcinoma; OS, overall survival; PFS, progression-free survival. Primary insurance status was categorized into three groups—patients with Medicare, private insurance, and ...

Colorectal cancer (CRC), the second leading cause of cancer-related deaths in the United States, is increasingly linked to ...